We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$95.5B
1-Year Est. Return
28.4%
This Fund
S&P 500
This Quarter
Est. Return
+1.76%
1 Year Est. Return
+28.4%
3 Year Est. Return
+84.58%
5 Year Est. Return
+116.72%
10 Year Est. Return
+426.49%
AUM
$82.7B
AUM Growth
+$473M
(+0.58%)
Cap. Flow
+$823M
Cap. Flow
% of AUM
0.99%
Top 10 Holdings %
Top 10 Hldgs %
14.9%
Holding
783
New
76
Increased
301
Reduced
323
Closed
81
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Coca-Cola
KO
|
+$598M |
| 2 |
Apollo Global Management
APO
|
+$418M |
| 3 |
Allstate
ALL
|
+$416M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$385M |
| 5 |
Quest Diagnostics
DGX
|
+$377M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$431M |
| 2 |
Delta Air Lines
DAL
|
+$318M |
| 3 |
Deere & Co
DE
|
+$282M |
| 4 |
Robert Half
RHI
|
+$270M |
| 5 |
Curtiss-Wright
CW
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 21.07% |
| 2 | Technology | 14.6% |
| 3 | Industrials | 13.72% |
| 4 | Healthcare | 11.92% |
| 5 | Consumer Discretionary | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SKX
401
DELISTED
Skechers
SKX
| $7.87M | 0.01% |
138,698
-5,222
| -4% | -$340K |
|
402
Jefferies Financial Group
JEF
$13.2B
| $7.84M | 0.01% |
146,466
-4,244
| -3% | -$288K |
|
403
Ero Copper
ERO
$2.67B
| $7.83M | 0.01% |
646,560
-454,705
| -41% | -$6.06M |
|
404
JD.com
JD
$42.9B
| $7.79M | 0.01% |
189,502
+87,904
| +87% | +$3.53M |
|
|
SF
405
Stifel
SF
$12.8B
| $7.75M | 0.01% |
123,432
+98,137
| +388% | +$6.92M |
|
406
First Horizon
FHN
$12.3B
| $7.68M | 0.01% |
+395,718
| New | +$8.15M |
|
407
Expro Ltd
XPRO
$1.75B
| $7.67M | 0.01% |
772,428
+744,469
| +2,663% | +$9.18M |
|
408
Sony
SONY
$133B
| $7.48M | 0.01% |
295,350
+51,980
| +21% | +$1.2M |
|
409
Albertsons Companies
ACI
$5.67B
| $7.42M | 0.01% |
+337,470
| New | +$6.96M |
|
410
Universal Technical Institute
UTI
$2.15B
| $7.34M | 0.01% |
285,743
-10,051
| -3% | -$271K |
|
411
Sociedad Química y Minera de Chile
SQM
$19.1B
| $7.32M | 0.01% |
184,357
+74,947
| +69% | +$3.01M |
|
412
Century Aluminum
CENX
$4.35B
| $7.31M | 0.01% |
+393,924
| New | +$7.57M |
|
413
Carriage Services
CSV
$648M
| $7.31M | 0.01% |
188,525
-2,199
| -1% | -$87.3K |
|
414
Assurant
AIZ
$14B
| $6.95M | 0.01% |
33,152
-503
| -1% | -$105K |
|
415
Universal Health Services
UHS
$10.1B
| $6.77M | 0.01% |
36,054
-841
| -2% | -$153K |
|
416
Unum
UNM
$14B
| $6.73M | 0.01% |
+82,634
| New | +$6.37M |
|
417
Holley
HLLY
$336M
| $6.68M | 0.01% |
2,600,799
+1,029,495
| +66% | +$2.89M |
|
418
Energy Transfer Partners
ET
$69.5B
| $6.65M | 0.01% |
+357,915
| New | +$6.97M |
|
419
KB Financial Group
KB
$40.6B
| $6.62M | 0.01% |
121,999
+26,548
| +28% | +$1.53M |
|
420
Crocs
CROX
$6.75B
| $6.49M | 0.01% |
61,193
+1,385
| +2% | +$144K |
|
421
Sumitomo Mitsui Financial
SMFG
$163B
| $6.47M | 0.01% |
421,483
+73,299
| +21% | +$1.11M |
|
422
Cemex
CX
$17.3B
| $6.36M | 0.01% |
+1,134,244
| New | +$6.86M |
|
423
Carlisle Companies
CSL
$14.1B
| $6.17M | 0.01% |
18,114
-6,843
| -27% | -$2.45M |
|
424
Matrix Service
MTRX
$324M
| $6.12M | 0.01% |
492,772
+437,222
| +787% | +$5.85M |
|
425
A.O. Smith
AOS
$8.82B
| $6.07M | 0.01% |
+99,507
| New | +$6.72M |
|
Similar funds
Boston Partners's Q1 2025 Portfolio in Review
As of Q1 2025, Boston Partners held 783 positions worth $82.7B, up 0.58% from $82.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Boston Partners's Q1 2025 filing shows 76 new, 301 increased, 323 reduced and 81 closed positions. Its largest new stake was Coca-Cola: 8,951,766 shares worth $642M. The largest sale was Amgen, an estimated $431M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 21% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2025 buy was Coca-Cola: 8,951,766 shares worth $642M.
- Boston Partners added most to Allstate in Q1 2025, an estimated $416M increase.
- Boston Partners's biggest Q1 2025 reduction was Amgen, cutting an estimated $431M.
- Boston Partners fully exited Hologic in Q1 2025, selling an estimated $258M.
- Boston Partners's ten largest holdings make up 15% of its $82.7B portfolio in Q1 2025.
- Boston Partners opened 76 new positions and closed 81 in Q1 2025.
- Boston Partners's portfolio value rose 0.58% quarter-over-quarter to $82.7B.
Based on Boston Partners's 13F filing for Q1 2025, filed 13 May 2025.